Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03506451 · ClinicalTrials.gov registry record · NA

PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study

A NA study of Head and Neck Cancer, sponsored by Duke University.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT03506451 is a NA study of Head and Neck Cancer that is active but no longer recruiting, run by Duke University. The registered enrollment target is 60 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03506451, a NA study of Head and Neck Cancer, is active but no longer recruiting, sponsored by Duke University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this single institution, pilot study is to explore the out of pocket (OOP)costs and financial toxicity of cancer care for patients during definitive treatment of head and neck cancer with radiation therapy with or without chemotherapy and surgical resection. The study team will assess how the financial burden of cancer care impacts quality of life as well as treatment-related decision-making from a patient perspective.

Conditions Studied

Interventions

  • OTHER Demographics questionnaires and the FACT HN questionnaire

Study Locations (1)

North Carolina

  • Duke Cancer Center - Durham

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2018-06-19
Est. Completion 2026-10-07
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03506451

The ClinicalTrials.gov registry entry for NCT03506451 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (77% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which Demographics questionnaires and the FACT HN questionnaire is the first listed.

NCT03506451 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03506451 about?

NCT03506451 is a clinical study titled "PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study". The purpose of this single institution, pilot study is to explore the out of pocket (OOP)costs and financial toxicity of cancer care for patients during definitive treatment of head and neck cancer with radiation therapy with or without chemotherapy and surgical resection. The study team will assess...

What is the current status of trial NCT03506451?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2018-06-19. Estimated completion is 2026-10-07.

What conditions does trial NCT03506451 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT03506451?

The interventions under investigation include: Demographics questionnaires and the FACT HN questionnaire (OTHER).

Who is sponsoring clinical trial NCT03506451?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03506451 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.